Clinical Trial Update: Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

This entry covers a Phase 2 trial of paclitaxel and cisplatin as first-line therapy for ovarian epithelial cancer across stages I-IV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN